Renaissance Technologies - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,133
+41.3%
130,800
+11.0%
0.01%
+66.7%
Q1 2023$2,217
-55.9%
117,800
-62.7%
0.00%
-57.1%
Q4 2022$5,026
-99.2%
315,700
+737.4%
0.01%
+600.0%
Q3 2022$617,000
+75.8%
37,700
+160.0%
0.00%
Q1 2022$351,000
-97.7%
14,500
-97.5%
0.00%
-100.0%
Q1 2021$14,990,000
+53.7%
581,000
+218.5%
0.02%
+72.7%
Q4 2020$9,751,000
-12.3%
182,400
-32.3%
0.01%0.0%
Q3 2020$11,117,000
+104.4%
269,500
+140.2%
0.01%
+120.0%
Q2 2020$5,438,000
+111.7%
112,200
+84.5%
0.01%
+150.0%
Q1 2020$2,569,000
-91.8%
60,800
-91.7%
0.00%
-91.7%
Q4 2019$31,272,000
+912.7%
731,000
+752.0%
0.02%
+700.0%
Q3 2019$3,088,000
-68.1%
85,800
-85.6%
0.00%
-72.7%
Q4 2018$9,666,000
+170.2%
597,800
+247.0%
0.01%
+175.0%
Q3 2018$3,577,000
+5.0%
172,300
-22.8%
0.00%
+100.0%
Q2 2018$3,408,000223,2000.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 432,317$11,154,0004.70%
Baker Brothers Advisors 41,910,704$1,081,296,0004.69%
Palo Alto Investors LP 2,337,877$60,317,0003.44%
Birchview Capital, LP 177,000$4,567,0002.71%
Longitude (Cayman) Ltd. 188,000$4,850,0001.86%
GREAT POINT PARTNERS LLC 311,217$8,029,0001.66%
Avoro Capital Advisors LLC 2,500,000$64,500,0001.11%
PFM Health Sciences, LP 1,302,129$33,595,0001.03%
HealthCor Management, L.P. 900,490$23,233,0000.82%
Eversept Partners, LP 420,000$10,836,0000.82%
View complete list of ACADIA PHARMACEUTICALS INC shareholders